Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

LMNX:US

17.9700 USD 0.0300 0.17%

As of 20:10:00 ET on 01/27/2015.

Snapshot for Luminex Corp (LMNX)

Open: 17.7400 Day's Range: 17.8200 - 18.2300 Volume: 249,268
Previous Close: 18.0000 52wk Range: 15.7400 - 21.6900 1-Yr Rtn: -2.07%

Stock Chart for LMNX

No chart data available.
  • LMNX:US 17.9900
  • 1D
  • 1M
  • 1Y
18.0000
Interactive LMNX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LMNX

Current P/E Ratio (ttm) 28.5166
Estimated P/E(12/2014) 24.2510
Relative P/E vs. SPX 1.5972
Earnings Per Share (USD) (ttm) 0.6302
Est. EPS (USD) (12/2014) 0.7410
Est. PEG Ratio -
Market Cap (M USD) 769.71
Shares Outstanding (M) 42.83
30 Day Average Volume 189,531
Price/Book (mrq) 2.5424
Price/Sale (ttm) 3.3195
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/02/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LMNX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LMNX

Luminex Corporation develops, manufactures and markets biological testing technologies with applications throughout the clinical diagnostic and life science industries. The Company's open-architecture technologies enable large numbers of biological tests (bioassays) to be conducted and analyzed quickly and accurately.

Nachum Shamir "Homi"President/CEOHarriss T CurrieSenior VP:Finance/CFO
Jeremy K Bridge-CookSenior VP:Research & DevMichael F PintekSenior VP:Operations
More Company Profile & Key Executives for LMNX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil